cs analysis just posted. Sequenom Inc. (Nasdaq: SQNM) is seeing interest late in the session on positive chatter related to research and development news on its Trisomy 21 (Down syndrome) test. Shares up 8.7% in afternoon action.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.